TPC0539
Galanthamine base;(4as,6r,8as)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6h-benzofuro[3a,3,2-ef][2]benzazepin-6-ol;GALANTAMINE;GALANTHAMINE;GALANTHAMINE HYDROCHLORIDE;6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS-(4aalpha,6beta,8aR*))-;6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methox;Galantamin;Jilkon;Lycoremin;Lycoremine;y-11-methyl-;Galanthamine HBr CP2000;Galanthamine HCl;GalanthamineHydrobromideBase;FumalicAcid;Galantaminehydrochloride;(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofurol[3a,3,2,-ef][2]benzazepin-6-ol;6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3 -methoxy-11-methyl-, (4aS,6R,8aS)-,;DANSHEN P.E.FOR INJECTION;GALANTHAMINE(P);Galantamine Hydrobromide;(-)-Galanthamine;Razadyne;Galanthaminum;Nivalin;Razadyne ER;Galantaminum [INN-Latin];Galantamina [INN-Spanish];Galantamina;Reminyl (TN);0D3Q044KCA;Galantaminum;(-)-Galantamine;GNT;Galantamine [USAN:INN];6H-Benzofuro[3a,3,;Galanthamine
C17H21NO3
287.35
